Functions of NF-κB1 and NF-κB2 in immune cell biology

Medzhitov, 2001, Toll-like receptors and innate immunity, Nat. Rev. Immunol., 1, 135, 10.1038/35100529

Takeda, 2003, Toll-like receptors, Annu. Rev. Immunol., 21, 335, 10.1146/annurev.immunol.21.120601.141126

Zhang, 2001, Toll-like receptor-mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity, J. Clin. Invest., 107, 13, 10.1172/JCI11837

O'Neill, 2000, The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense, Immunol. Today, 21, 206, 10.1016/S0167-5699(00)01611-X

Wallach, 1999, Tumor necrosis factor receptor and Fas signaling mechanisms, Annu. Rev. Immunol., 17, 331, 10.1146/annurev.immunol.17.1.331

Li, 2002, NF-κB regulation in the immune system, Nat. Rev. Immunol., 2, 725, 10.1038/nri910

Weih, 2003, Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway, Immunol. Rev., 195, 91, 10.1034/j.1600-065X.2003.00064.x

Claudio, 2002, BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells, Nat. Immunol., 3, 958, 10.1038/ni842

Girardin, 2003, Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing, Trends Immunol., 24, 652, 10.1016/j.it.2003.10.007

Feldmann, 2001, Anti-TNFα therapy of rheumatoid arthritis: what have we learned?, Annu. Rev. Immunol., 19, 163, 10.1146/annurev.immunol.19.1.163

Karin, 2002, NF-κB at the crossroads of life and death, Nat. Immunol., 3, 221, 10.1038/ni0302-221

Karin, 2002, NF-κB in cancer: from innocent bystander to major culprit, Nat. Rev. Cancer, 2, 301, 10.1038/nrc780

Farrow, 2002, Inflammation and the development of pancreatic cancer, Surg. Oncol., 10, 153, 10.1016/S0960-7404(02)00015-4

Normark, 2003, Persistent infection with Helicobacter pylori and the development of gastric cancer, Adv. Cancer Res., 90, 63, 10.1016/S0065-230X(03)90002-9

Ghosh, 1998, NF-κB and Rel proteins: evolutionary conserved mediators of immune responses, Annu. Rev. Immunol., 16, 225, 10.1146/annurev.immunol.16.1.225

Marienfeld, 2003, RelB forms transcriptionally inactive complexes with RelA/p65, J. Biol. Chem., 278, 19852, 10.1074/jbc.M301945200

Bours, 1993, The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers, Cell, 72, 729, 10.1016/0092-8674(93)90401-B

Franzoso, 1992, The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB mediated inhibition, Nature (London), 359, 339, 10.1038/359339a0

Fujita, 1993, The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through p50 homodimers, Genes Dev., 7, 1354, 10.1101/gad.7.7b.1354

Chen, 2004, Shaping the nuclear action of NF-κB, Nat. Immunol. Rev., 5, 392, 10.1038/nrm1368

Gerondakis, 1993, The activity of a 70kDa IκB molecule identical to the carboxyl terminus of the p105 NF-κB precursor is modulated by protein kinase A, Cell Growth Differ., 4, 617

Inoue, 1992, IκBγ, a 70 kDa protein identical to the C-terminal half of p100 NF-κB: a new member of the IκB family, Cell, 68, 1109, 10.1016/0092-8674(92)90082-N

Pomerantz, 2002, Two pathways to NF-κB, Mol. Cell, 10, 693, 10.1016/S1097-2765(02)00697-4

Karin, 2000, Phosphorylation meets ubiquitination: the control of NF-κB activity, Annu. Rev. Immunol., 18, 621, 10.1146/annurev.immunol.18.1.621

Yang, 2001, The essential role of MEKK3 in TNF-induced NF-κB activation, Nat. Immunol., 2, 620, 10.1038/89769

Takaesu, 2003, TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway, J. Mol. Biol., 326, 105, 10.1016/S0022-2836(02)01404-3

Liu, 2004, Ubiquitin ligases and the immune response, Annu. Rev. Immunol., 22, 81, 10.1146/annurev.immunol.22.012703.104813

Ben-Neriah, 2002, Regulatory functions of ubiquitination in the immune system, Nat. Immunol., 3, 20, 10.1038/ni0102-20

Silverman, 2001, NF-κB signaling pathways in mammalian and insect innate immunity, Genes Dev., 15, 2321, 10.1101/gad.909001

Hoffmann, 2003, The immune response of Drosophila, Nature (London), 426, 33, 10.1038/nature02021

Hultmark, 2003, Drosophila immunity: paths and patterns, Curr. Opin. Immunol., 15, 12, 10.1016/S0952-7915(02)00005-5

Morisato, 1995, Signaling pathways that establish the dorsal–ventral pattern of the Drosophila embryo, Annu. Rev. Genet., 29, 371, 10.1146/annurev.ge.29.120195.002103

Silverman, 2000, A Drosophila IκB kinase complex required for Relish cleavage and antibacterial immunity, Genes Dev., 14, 2461, 10.1101/gad.817800

Stoven, 2000, Activation of the Drosophila NF-κB factor Relish by rapid endoproteolytic cleavage, EMBO Rep., 1, 347, 10.1093/embo-reports/kvd072

Stoven, 2003, Caspase-mediated processing of the Drosophila NF-κB factor Relish, Proc. Natl. Acad. Sci. U.S.A., 100, 5991, 10.1073/pnas.1035902100

Ishikawa, 1997, Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2, J. Exp. Med., 186, 999, 10.1084/jem.186.7.999

Scheinman, 1993, NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule, Mol. Cell. Biol., 13, 6089

Mercurio, 1993, p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction, Genes Dev., 7, 705, 10.1101/gad.7.4.705

Dobrzanski, 1995, Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100, Oncogene, 10, 1003

Solan, 2001, RelB cellular regulation and transcriptional activity are regulated by p100, J. Biol. Chem., 277, 1405, 10.1074/jbc.M109619200

Yilmaz, 2003, RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF, EMBO J., 22, 121, 10.1093/emboj/cdg004

Caamano, 1998, Nuclear Factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses, J. Exp. Med., 187, 185, 10.1084/jem.187.2.185

Franzoso, 1998, Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture, J. Exp. Med., 187, 147, 10.1084/jem.187.2.147

Senftleben, 2001, Activation by IKKα of a second evolutionary conserved, NF-κB signaling pathway, Science, 293, 1495, 10.1126/science.1062677

Yamada, 2000, Abnormal immune function of hematopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase, J. Immunol., 165, 804, 10.4049/jimmunol.165.2.804

Xiao, 2001, NF-κB-inducing kinase regulates the processing of NF-κB2 p100, Mol. Cell, 7, 401, 10.1016/S1097-2765(01)00187-3

Koike, 1996, The splenic marginal zone is absent in alymphoplastic aly mutant mice, Eur. J. Immunol., 26, 669, 10.1002/eji.1830260324

Yin, 2001, Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice, Science, 291, 2162, 10.1126/science.1058453

Miyawaki, 1994, A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice, Eur. J. Immunol., 24, 429, 10.1002/eji.1830240224

Kaisho, 2001, IκB kinase α is essential for mature B cell development and function, J. Exp. Med., 193, 417, 10.1084/jem.193.4.417

Regnier, 1997, Identification and characterization of an IκB kinase, Cell, 90, 373, 10.1016/S0092-8674(00)80344-X

Ling, 1998, NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176, Proc. Natl. Acad. Sci. U.S.A., 95, 3792, 10.1073/pnas.95.7.3792

Xiao, 2001, Retroviral oncoprotein Tax induces processing of NF-κB2/p100 in T cells: evidence for the involvement of IKKα, EMBO J., 20, 6805, 10.1093/emboj/20.23.6805

Derudder, 2003, RelB/p50 dimers are differentially regulated by tumor necrosis factor-α and lymphotoxin-β receptor activation, J. Biol. Chem., 278, 23278, 10.1074/jbc.M300106200

Gommerman, 2003, Lymphotoxin/LIGHT, lymphoid microenviroments and autoimmunedisease, Nat. Immunol. Rev., 3, 642, 10.1038/nri1151

Muller, 2003, Lymphotoxin β receptor induces sequential activation of distinct NF-κB factors via separate signaling pathways, J. Biol. Chem., 278, 12006, 10.1074/jbc.M210768200

Dejardin, 2002, The lymphotoxin-β receptor induces different pathways of gene expression via two NF-κB pathways, Immunity, 17, 525, 10.1016/S1074-7613(02)00423-5

Karrer, 2000, Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect in secondary lymphoid organs and functional B cell defect, Eur. J. Immunol., 30, 2799, 10.1002/1521-4141(200010)30:10<2799::AID-IMMU2799>3.0.CO;2-2

Ware, 1995, The ligands and receptors of the lymphotoxin system, Curr. Top. Microbiol. Immunol., 198, 175

Kayagaki, 2002, BAFF/BLys receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2, Immunity, 10, 515, 10.1016/S1074-7613(02)00425-9

Coope, 2002, CD40 regulates the processing of NF-κB2 p100 to p52, EMBO J., 21, 5375, 10.1093/emboj/cdf542

Mackay, 2003, BAFF and APRIL: a tutorial on B cell survival, Annu. Rev. Immunol., 21, 231, 10.1146/annurev.immunol.21.120601.141152

Zarnegar, 2004, Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways, Proc. Natl. Acad. Sci. U.S.A., 101, 8108, 10.1073/pnas.0402629101

Teitelbaum, 2000, Bone resorption by osteoclasts, Science, 289, 1504, 10.1126/science.289.5484.1504

Novack, 2003, The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis, J. Exp. Med., 198, 771, 10.1084/jem.20030116

Saitoh, 2003, TWEAK induces NF-κB2 p100 processing and long-lasting NF-κB activation, J. Biol. Chem., 278, 36005, 10.1074/jbc.M304266200

Saccani, 2003, Modulation of NF-κB activity by exchange of dimers, Mol. Cell, 11, 1563, 10.1016/S1097-2765(03)00227-2

Mordmuller, 2003, Lymphotoxin and lipopolysaccharide induce NF-κB p52 generation by a co-translational mechanism, EMBO Rep., 4, 82, 10.1038/sj.embor.embor710

Ekengren, 1999, Drosophila cecropin as an antifungal agent, Insect Biochem. Mol. Biol., 29, 965, 10.1016/S0965-1748(99)00071-5

Malinin, 1997, MAP 3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1, Nature (London), 385, 540, 10.1038/385540a0

Wajant, 2001, The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators, Cell. Signalling, 13, 389, 10.1016/S0898-6568(01)00160-7

Grammer, 2001, CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms, Adv. Immunol., 76, 61, 10.1016/S0065-2776(01)76019-1

Saito, 2003, Two carboxy-terminal activation regions of Epstein–Barr virus latent membrane protein 1 activate NF-κB through distinct signaling pathways in fibroblast cell lines, J. Biol. Chem., 278, 46565, 10.1074/jbc.M302549200

Tada, 2001, Critical roles of TRAF2 and TRAF5 in TNF-induced NF-κB activaiton and protection from cell death, J. Biol. Chem., 276, 36530, 10.1074/jbc.M104837200

Wang, 2001, TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature (London), 412, 346, 10.1038/35085597

Sun, 2004, The novel functions of ubiquitination in signaling, Curr. Opin. Cell Biol., 16, 1

Kovalenko, 2003, The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination, Nature (London), 424, 801, 10.1038/nature01802

Trompouki, 2003, CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members, Nature (London), 424, 793, 10.1038/nature01803

Liao, 2004, Regulation of the NF-κB inducing kinase by TRAF3-induced degradation, J. Biol. Chem., 279, 26243, 10.1074/jbc.M403286200

Atkinson, 2004, Latent membrane protein 1 of Epstein–Barr virus stimulates processing of NF-κB p100 to p52, J. Biol. Chem., 279, 51134

Fong, 2002, Genetic evidence for the essential role of β-transducin repeat-containing protein in the inducible processing of NF-κB2/p100, J. Biol. Chem., 277, 22111, 10.1074/jbc.C200151200

Amir, 2004, Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase, Oncogene, 23, 2540, 10.1038/sj.onc.1207366

Fong, 2002, S9, a 19 S proteasome subunit interacting with ubiquitinated NF-κB2/p100, J. Biol. Chem., 277, 40697, 10.1074/jbc.M205330200

Heusch, 1999, The generation of nfkb2 p52: mechanism and efficiency, Oncogene, 18, 6201, 10.1038/sj.onc.1203022

Liao, 2003, Regulation of NF-κB2/p100 processing by its nuclear shuttling, Oncogene, 22, 4868, 10.1038/sj.onc.1206761

Rayet, 1999, Aberrant rel/nfkb genes and activity in human cancer, Oncogene, 18, 6938, 10.1038/sj.onc.1203221

Ciana, 1997, Constitutive expression of lymphoma-associated NF-κB/Lyt-10 proteins is tumorigenic in murine fibroblasts, Oncogene, 14, 1805, 10.1038/sj.onc.1201015

Chang, 1995, Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators, Mol. Cell. Biol., 15, 5180, 10.1128/MCB.15.9.5180

Kim, 2000, Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes, Oncogene, 19, 1334, 10.1038/sj.onc.1203432

Westerheide, 2001, The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition, Mol. Cell. Biol., 21, 8428, 10.1128/MCB.21.24.8428-8436.2001

Viatour, 2003, NF-κB2/p100 induces Bcl-2 expression, Leukemia, 17, 1349, 10.1038/sj.leu.2402982

Lanoix, 1994, Overproduction of NF-κB2 (lyt-10) and c-Rel: a mechanism for HTLV-1 Tax-mediated trans-activation via the NF-κB signaling pathway, Oncogene, 9, 841

Eliopoulos, 2003, Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway, Oncogene, 22, 7557, 10.1038/sj.onc.1207120

Luftig, 2004, Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent non-canonical NF-κB activation, Proc. Natl. Acad. Sci. U.S.A., 101, 141, 10.1073/pnas.2237183100

Geleziunas, 1998, Human T cell leukemia virus type I Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases, Mol. Cell. Biol., 18, 5157, 10.1128/MCB.18.9.5157

Chu, 1998, The Tax oncoprotein of human T cell leukemia virus type I associates with and persistently activates IκB kinases containing IKKα and IKKβ, J. Biol. Chem., 273, 15891, 10.1074/jbc.273.26.15891

Hatzivassiliou, 2002, Cellular signaling pathways engaged by the Epstein–Barr virus transforming protein LMP1, Front. Biosci., 7, 319, 10.2741/hatziva

Wang, 2002, NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function, Nat. Cell Biol., 4, 888, 10.1038/ncb872

Hacker, 2002, Is NF-κB2/p100 a direct activator of programmed cell death?, Cancer Cell, 2, 431, 10.1016/S1535-6108(02)00213-1

Rice, 1992, The precursor of NF-κB p50 has IκB-like functions, Cell, 71, 243, 10.1016/0092-8674(92)90353-E

Ishikawa, 1998, Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p) 105 precursor (NF-κB1) but expressing p50, J. Exp. Med., 187, 985, 10.1084/jem.187.7.985

Liou, 1992, The NF-κB p50 precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50, EMBO J., 11, 3003, 10.1002/j.1460-2075.1992.tb05370.x

Ciechanover, 2000, Ubiquitin-mediated proteolysis: biological regulation via destruction, Bioessays, 22, 442, 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q

Rape, 2002, Taking a bite: proteasomal protein processing, Nat. Cell Biol., 4, 113, 10.1038/ncb0502-e113

Lin, 1996, A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit, Mol. Cell. Biol., 16, 2248, 10.1128/MCB.16.5.2248

Betts, 1996, Differential regulation of NF-κB2 (p100) processing and control by amino-terminal sequences, Mol. Cell. Biol., 16, 6363, 10.1128/MCB.16.11.6363

Orian, 1999, Structural motifs involves in ubiquitin-mediated processing of the NF-κB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain, Mol. Cell. Biol., 19, 3664, 10.1128/MCB.19.5.3664

Levitskaya, 1997, Inhibition of ubiquitination/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1, Proc. Natl. Acad. Sci. U.S.A., 94, 12616, 10.1073/pnas.94.23.12616

Sharipo, 1998, A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: a new mechanism for selective inhibition of proteolysis, Nat. Med., 4, 939, 10.1038/nm0898-939

Liu, 2003, Endoproteolytic activity of the proteasome, Science, 299, 408, 10.1126/science.1079293

Lee, 2001, ATP-dependent proteases degrade their substrates by processively unraveling them for the degradation signal, Mol. Cell, 7, 627, 10.1016/S1097-2765(01)00209-X

Cohen, 2001, Processing of p105 is inhibited by docking of p50 active subunits to teh ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ubiquitin-ligase binding domain, J. Biol. Chem., 276, 26769, 10.1074/jbc.M102448200

Harhaj, 1996, Inhibition of p105 processing by NF-κB proteins in transiently transfected cells, Oncogene, 12, 2385

Maier, 2003, Critical role of RelB serine 368 for dimerization and p100 stabilization, J. Biol. Chem., 278, 39242, 10.1074/jbc.M301521200

Lin, 1998, Cotranslational biogenesis of NF-κB p50 by the 26 S proteasome, Cell, 92, 819, 10.1016/S0092-8674(00)81409-9

Fan, 1991, Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway, Nature (London), 354, 395, 10.1038/354395a0

Li, 2000, Cotranslational dimerization of the Rel homology domain of NF-κB1 generates p50–p105 heterodimers and is required for effective p50 dimerization, EMBO J., 19, 4712, 10.1093/emboj/19.17.4712

Donald, 1995, Proteolytic processing of NF-κB/IκB in human monocytes, J. Biol. Chem., 270, 9, 10.1074/jbc.270.1.9

Belich, 1999, TPL-2 kinase regulates the proteolysis of the NF-κB inhibitory protein NF-κB1 p105, Nature (London), 397, 363, 10.1038/16946

MacKichan, 1996, Phosphorylation of p105 PEST sequences via a redox-insensitive pathway up-regulates processing to p50 NF-κB, J. Biol. Chem., 271, 6084, 10.1074/jbc.271.11.6084

Mellits, 1993, Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of of NF-κB, Nucleic Acids Res., 21, 5059, 10.1093/nar/21.22.5059

Salmeron, 2001, Direct phosphorylation of NF-κB p105 by the IκB kinase complex on serine 927 is essential for signal-induced p105 proteolysis, J. Biol. Chem., 276, 22215, 10.1074/jbc.M101754200

Lang, 2003, βTrCP-mediated proteolysis of NF-κB1 p105 requires phosphorylation of p105 serines 927 and 932, Mol. Cell. Biol., 23, 402, 10.1128/MCB.23.1.402-413.2003

Heissmeyer, 2001, Shared pathways of IκB kinase-induced SCFβTrCP-mediated ubiquitination and degradation for the NF-κB precursor p105 and IκBα, Mol. Cell. Biol., 21, 1024, 10.1128/MCB.21.4.1024-1035.2001

Beinke, 2002, The death domain of NF-κB1 p105 is essential for signal-induced p105 proteolysis, J. Biol. Chem., 277, 24162, 10.1074/jbc.M201576200

Heissmeyer, 1999, NF-κB p105 is a target on IkB kinases and controls signal induction of BCL-3–p50 complexes, EMBO J., 18, 4766, 10.1093/emboj/18.17.4766

Orian, 2000, SCFβTrCP ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase, EMBO J., 19, 2580, 10.1093/emboj/19.11.2580

Syrovets, 2001, Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK-β-mediated NF-κB activation, Blood, 97, 3941, 10.1182/blood.V97.12.3941

Ten, 1992, The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation, EMBO. J., 11, 195, 10.1002/j.1460-2075.1992.tb05042.x

Cohen, 2004, Dual effects of IκB kinase β-mediated phosphorylation on p105 fate: SCFβ-TrCP-dependent degradation and SCFβ-TrCP-independent processing, Mol. Cell. Biol., 24, 475, 10.1128/MCB.24.1.475-486.2004

Wu, 2003, Structure of a β-TrCP1–Skp1–β-catenin complex: destruction motif binding and lysine specificity of the SCFβTrCP1 ubiquitin ligase, Genes Dev., 11, 1445

Demarchi, 2003, Glycogen synthase-3β regulates NF-κB1/p105 stability, J. Biol. Chem., 278, 39583, 10.1074/jbc.M305676200

Demarchi, 2001, Gas6 anti-apoptotic signaling requires NF-κB activation, J. Biol. Chem., 276, 31738, 10.1074/jbc.M104457200

Takeda, 2004, TLR signaling pathways, Semin. Immunol., 16, 3, 10.1016/j.smim.2003.10.003

Patriotis, 1993, Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T cell lymphomas and in T cell activation Proc, Natl. Acad. Sci. U.S.A., 90, 2251, 10.1073/pnas.90.6.2251

Miyoshi, 1991, Structure and transforming potential of the human cot oncogene encoding a putative protein kinase, Mol. Cell. Biol., 11, 4088

Salmeron, 1996, Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase, EMBO J., 15, 817, 10.1002/j.1460-2075.1996.tb00417.x

Dumitru, 2000, TNFα induction by LPS is regulated post-transcriptionally via a TPL2/ERK-dependent pathway, Cell, 103, 1071, 10.1016/S0092-8674(00)00210-5

Eliopoulos, 2002, Induction of COX-2 by LPS in macrophages is regulated by TPL2-dependent CREB activation signals, EMBO J., 21, 4831, 10.1093/emboj/cdf478

Eliopoulos, 2003, TPL-2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40, EMBO J., 22, 3855, 10.1093/emboj/cdg386

Beinke, 2003, NF-κB p105 negatively regulates TPL-2 MEK kinase activity, Mol. Cell. Biol., 23, 4739, 10.1128/MCB.23.14.4739-4752.2003

Lang, 2004, ABIN2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability, Mol. Cell. Biol., 24, 5235, 10.1128/MCB.24.12.5235-5248.2004

Waterfield, 2003, NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the TPL-2 kinase, Mol. Cell, 11, 685, 10.1016/S1097-2765(03)00070-4

Ceci, 1997, TPL-2 is an oncogenic kinase that is activated by carboxy-terminal truncation, Genes Dev., 11, 688, 10.1101/gad.11.6.688

Swantek, 1999, Lipopolysaccaride-induced tumor necrosis factor-α promoter activity is inhibitor of nuclear factor-κB kinase dependent, J. Biol. Chem., 274, 11667, 10.1074/jbc.274.17.11667

Chen, 2001, Tumor necrosis factor-α-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IκB kinase 1/2 in human alveolar epithelial cells, Mol. Pharmacol., 59, 493, 10.1124/mol.59.3.493

Caivano, 2001, The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein β (C/EBP β) and C/EBPδ transcript, J. Biol. Chem., 276, 48693, 10.1074/jbc.M108282200

Park, 2004, Targeting of TAK1 by the NF-κB protein Relish regulates the JNK-mediated immune response in Drosophila, Genes Dev., 18, 584, 10.1101/gad.1168104

Varfolomeev, 2004, Tumor necrosis factor: an apoptosis JuNKie?, Cell, 116, 491, 10.1016/S0092-8674(04)00166-7

Ferrier, 1999, Physical interaction of the bHLH LYL1 protein and NF-κB1 p105, Oncogene, 18, 995, 10.1038/sj.onc.1202374

Baer, 1993, TAL1, TAL2 and LYL1: a family of basic helix–loop–helix proteins implicated in T cell acute leukaemia, Semin. Cancer Biol., 4, 341

Li, 2003, Casper/c-FLIP is physically and functionally associated with NF-κB1 p105, Biochem. Biophys. Res. Commun., 309, 980, 10.1016/j.bbrc.2003.08.104

Krueger, 2001, FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis, Mol. Cell. Biol., 21, 8247, 10.1128/MCB.21.24.8247-8254.2001

Bouwmeester, 2004, A physical and functional map of the human TNFα/NF-κB signal transduction pathway, Nat. Cell Biol., 6, 97, 10.1038/ncb1086

van Huffel, 2001, Identification of a novel A20-binding inhibitor of nuclear factor-κB activation termed ABIN-2, J. Biol. Chem., 276, 30216, 10.1074/jbc.M100048200

Beyaert, 2000, A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis, Biochem. Pharmacol., 60, 1143, 10.1016/S0006-2952(00)00404-4

Lee, 2000, Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice, Science, 289, 2350, 10.1126/science.289.5488.2350

Sha, 1995, Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses, Cell, 80, 321, 10.1016/0092-8674(95)90415-8

Grumont, 1998, B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells, J. Exp. Med., 187, 663, 10.1084/jem.187.5.663

Sha, 1995, Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses, Cell, 80, 321, 10.1016/0092-8674(95)90415-8

Snapper, 1996, B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching, J. Immunol., 156, 183, 10.4049/jimmunol.156.1.183

Zheng, 2001, NF-κB RelA (p65) is essential for TNF-α-induced Fas expression but dispensable for both TCR-induced expression and activation-induced cell death, J. Immunol., 166, 4949, 10.4049/jimmunol.166.8.4949

Artis, 2003, NF-κB1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major, J. Immunol., 170, 1995, 10.4049/jimmunol.170.4.1995

Artis, 2002, Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation, J. Immunol., 169, 4481, 10.4049/jimmunol.169.8.4481

Das, 2001, A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation, Nat. Immunol., 2, 45, 10.1038/83158

Kanters, 2004, Hematopoietic NF-κB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype, Blood, 103, 934, 10.1182/blood-2003-05-1450

Bohuslav, 1998, Regulation of an essential innate immune response by the p50 subunit of NF-κB, J. Clin. Invest., 102, 1645, 10.1172/JCI3877

Lamhamedi-Cherradi, 2003, Transcriptional regulation of type I diabetes by NF-κB, J. Immunol., 171, 4886, 10.4049/jimmunol.171.9.4886

Campbell, 2000, Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis, J. Clin. Invest., 105, 1799, 10.1172/JCI8298

Yang, 1998, Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation, J. Exp. Med., 188, 1739, 10.1084/jem.188.9.1739

Erdman, 2001, Typhlocolitis in NF-κB-deficient mice, J. Immunol., 166, 1443, 10.4049/jimmunol.166.3.1443

Karban, 2004, Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis, Hum. Mol. Genet., 13, 35, 10.1093/hmg/ddh008

Ishikawa, 1996, Charaterization of ES cells deficient for the p105 precursor (NF-κB1): role of p50 NLS, Oncogene, 13, 255

Liptay, 1992, Related subunits of NF-κB map to two distinct loci associated with translations in leukemia, NF-κB1 and NF-κB2, Genomics, 13, 287, 10.1016/0888-7543(92)90244-M

Bours, 1994, The NF-κB transcription factor and cancer: high expression of NF-κB, Biochem. Pharmacol., 47, 145, 10.1016/0006-2952(94)90448-0

Mukhopadhyay, 1995, Altered expression of the p50 subunit of the NF-κB transcription factor complex in non-small cell lung carcinoma, Oncogene, 11, 999

Michaux, 1996, BCL3 rearrangement and t(14;19) (q32;q13) in lymphoproliferative disorders, Genes Chromosomes Cancer, 15, 38, 10.1002/(SICI)1098-2264(199601)15:1<38::AID-GCC6>3.0.CO;2-5

Lenardo, 1994, Bcl-3-mediated nuclear regulation of the NF-κB transactivating factor, Immunol. Today, 15, 145, 10.1016/0167-5699(94)90308-5

Ong, 1998, Lymphadenopathy, splenomegaly and altered immunoglobulin production in BCL-3 transgenic mice, Oncogene, 16, 2333, 10.1038/sj.onc.1201771

Thornburg, 2003, Activation of nuclear factor-κB p50 homodimer/BCL-3 complexes in nasopharyngeal carcinoma, Cancer Res., 63, 8293

Sun, 1999, Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: hijacking cellular IκB kinases, Oncogene, 18, 6948, 10.1038/sj.onc.1203220

Watanabe, 1993, HTLV-1 encoded Tax in association with NF-κB precursor p105 enhances nuclear localization of NF-κB p50 and p65 in transfected cells, Oncogene, 8, 2949

Hirai, 1992, Transcriptional activator Tax of HTLV-1 binds to the NF-κB precursor p105, Oncogene, 7, 1737

Munoz, 1994, Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκBα/MAD3, J. Virol., 68, 8035, 10.1128/jvi.68.12.8035-8044.1994

Rousset, 1996, Effects on NF-κB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome, Nature (London), 381, 328, 10.1038/381328a0

Karin, 2004, The IKK NF-κB system: a treasure trove for drug development, Nat. Rev. Drug Discov., 3, 17, 10.1038/nrd1279

Sun, 2003, Deregulation of NF-κB and its upstream kinases in cancer, Cancer Metastasis Rev., 22, 405, 10.1023/A:1023733231406

Kontoyiannis, 2002, Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease, J. Exp. Med., 196, 1563, 10.1084/jem.20020281

Locksley, 2001, The TNF and TNF receptor superfamilies: integrating mammalian biology, Cell, 104, 487, 10.1016/S0092-8674(01)00237-9

Marshall, 1994, MAP kinase kinase kinase, MAP kinase kinase and MAP kinase, Curr. Opin. Gene. Dev., 4, 82, 10.1016/0959-437X(94)90095-7

Caamano, 2000, Identification of a role for NF-κB2 in the regulation of apoptosis and in maintainance of T cell-mediated immunity to Toxoplasma gondii, J. Immunol., 165, 5720, 10.4049/jimmunol.165.10.5720

Weih, 1997, Multifocal defects in immune responses in RelB-deficient mice, J. Immunol., 158, 5211, 10.4049/jimmunol.158.11.5211

Weih, 2001, Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines, J. Immunol., 167, 1909, 10.4049/jimmunol.167.4.1909

Weih, 1995, Multiorgan inflammation and hematopoietic abnormalities in mice with targeted disruption of RelB, a member of the NF-κB/Rel family, Cell, 80, 331, 10.1016/0092-8674(95)90416-6

Snapper, 1996, B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching, J. Exp. Med., 184, 1537, 10.1084/jem.184.4.1537

Burkly, 1995, Expression of relB is required for the development of thymic medulla and dendritic cells, Nature (London), 373, 531, 10.1038/373531a0

Paxian, 2002, Abnormal organogenesis of Peyer's patches in mice deficient for NF-κB1, NF-κB2, and Bcl-3, Gastroenterology, 122, 1853, 10.1053/gast.2002.33651

Schwarz, 1997, Immunological defects in mice with a targeted disruption in Bcl-3, Genes Dev., 11, 187, 10.1101/gad.11.2.187

Matsumoto, 2002, Essential role of NF-κB-inducing kinase in T cell activation through the TCR/CD3 pathway, J. Immunol., 169, 1151, 10.4049/jimmunol.169.3.1151

Futterer, 1998, The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissue, Immunity, 9, 59, 10.1016/S1074-7613(00)80588-9